- Report
- October 2025
- 90 Pages
North America
From €2844EUR$3,250USD£2,473GBP
- Report
- June 2025
- 89 Pages
North America
From €3019EUR$3,450USD£2,625GBP
- Report
- June 2025
- 81 Pages
Africa, Middle East
From €3019EUR$3,450USD£2,625GBP
- Report
- June 2025
- 97 Pages
Asia Pacific
From €3457EUR$3,950USD£3,005GBP
- Report
- June 2025
- 100 Pages
Europe
From €3457EUR$3,950USD£3,005GBP
- Report
- June 2025
- 90 Pages
United States
From €1749EUR$1,999USD£1,521GBP
- Report
- February 2025
- 95 Pages
North America
From €5247EUR$5,995USD£4,561GBP
- Report
- February 2025
- 111 Pages
Europe
From €5247EUR$5,995USD£4,561GBP
- Report
- February 2025
- 107 Pages
Asia Pacific
From €5247EUR$5,995USD£4,561GBP
- Report
- November 2023
- 127 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €2048EUR$2,340USD£1,780GBP
€3151EUR$3,600USD£2,739GBP
- Report
- January 2023
- 127 Pages
Global
From €1969EUR$2,250USD£1,712GBP
- Report
- April 2021
Global
From €788EUR$900USD£685GBP
- Report
- March 2022
- 260 Pages
Global
From €3282EUR$3,750USD£2,853GBP
- Report
- February 2024
- 78 Pages
Global
From €2582EUR$2,950USD£2,244GBP
- Report
- February 2020
- 237 Pages
Global
From €2407EUR$2,750USD£2,092GBP
- Report
- February 2024
- 158 Pages
Global
From €4070EUR$4,650USD£3,538GBP
- Report
- August 2023
- 336 Pages
Global
From €4070EUR$4,650USD£3,538GBP
- Report
- January 2020
- 54 Pages
Global
From €1728EUR$1,975USD£1,503GBP
- Report
- December 2022
- 66 Pages
Global
From €3063EUR$3,500USD£2,663GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more